The intervention resulted in a higher exclusive breastfeeding rate, fewer infant illness visits, and overall cost savings in infant health care by the end of the second year, with significant economic benefits and improved health outcomes for infants.
The implementation of nirsevimab for all infants could avoid 18,249 RSV-related health outcomes, representing a 9.96% reduction in RSV-related hospitalizations and severe cases compared to standard care. The cost-effectiveness analysis indicated that nirsevimab is a cost-effective intervention at a price per dose of $692 at a willingness-to-pay threshold of $40,000 per quality-adjusted life year (QALY).
The study found that MgSO uptake increased in all maternity units, with the NPP achieving significant improvements in uptake rates. Enhanced support units reported better teamwork and understanding of the intervention, although it did not significantly improve uptake compared to standard support.
By 12 months corrected age, 5% of very preterm and 10% of moderately preterm infants were overweight, indicating some success in managing growth; however, nutrient-enriched feeds were associated with lower length z-scores in moderately preterm infants.
Low mortality rates in children due to COVID-19 across analyzed countries, with evidence suggesting that vaccination can help protect both vaccinated individuals and the broader community.
The study indicates that the majority of nosocomial RSV-related deaths can be prevented through effective infant-targeted immunization strategies, as more than half of the affected children were younger than 6 months of age.
The intervention improved child cognitive development and may have positively affected linear growth, with increased clinic visit attendance and improvements in language and motor development in the CCT group.
Positive outcomes include improved acceptability of care among health workers, alignment with national policies, and the potential to enhance routine care quality for at-risk infants and their mothers.
The study indicates that VAS has been shown to substantially reduce morbidity and mortality in preschool-age children, particularly in regions with high prevalence of VAD. Tracking and improving VAS coverage can lead to better health outcomes and reduced disparities in child health.
Improved quality of care and enhanced detection and prevention of child abuse through a structured coding system for medical evaluation notes.
Interventions that influenced placental phenotype were associated with improved maternal outcomes (69%) and better offspring birth outcomes (54%).
Significant improvement in knowledge scores among trained CHWs, high satisfaction reported by both CHWs and community members, and positive feedback on the content and usability of the application.
Significant increase in coverage of PCV-10 to 76% by 2014/15, nearly 100% community acceptability of vaccines, and a doubling of coverage for oral rehydration solutions for diarrhea treatment, indicating improved health-seeking behavior and access to care.
Enrollment in the ISVMP significantly reduces growth disparities among infants with HLHS. Infants with middle and high social vulnerability who were enrolled in the program gained more weight compared to pre-ISVMP controls, indicating improved growth outcomes.
Increased likelihood of medication prescription for children with anxiety+depression compared to those with only one diagnosis. Medication choices generally align with current treatment recommendations.
Obtaining consent for newborn procedures was associated with a 2.7 times greater likelihood of satisfaction with care, a 27% increase in postpartum visit attendance, and a 33% increase in exclusive breastfeeding at 10 weeks.
Infants in the supine group showed better motor development at 8 months compared to other groups, and most infants receiving guidance achieved normal motor development by the end of the first year.
Health visitors reported benefits such as opening conversations about the parent-infant relationship and identifying concerns, although challenges in implementation were noted.
Significant increases in antenatal care attendance (OR=1.89), tetanus toxoid immunization (OR=1.63), compliance with iron supplementation (OR=1.88), and postnatal care attendance (OR=2.54) were observed among mothers receiving mHealth interventions compared to the control group.
The study aims to estimate the impact of the NCHA program on reducing under-five mortality rates in rural Liberia, potentially demonstrating significant improvements in child health outcomes due to increased healthcare access and treatment.
Expected positive outcomes include improved child-parent relationship quality and enhanced parental reflective functioning, leading to better socioemotional development in children.
Increased food responsiveness in children, decreased emotional over/undereating, improved awareness and knowledge-sharing among participants, and a decrease in force-feeding practices observed.
Some programs showed promise in improving child behavioral and emotional functioning, but the overall effectiveness in the context of homelessness remains under-researched. Evidence-based programs aim to reduce risks of mental health problems in infants.
The study found that 15.8% of infants presented warning signs, with a significant association between being male and having sleep disorders with increased likelihood of warning signs. Reading aloud was identified as a protective factor. Additionally, parental distress was more prevalent in children with warning signs, indicating the importance of addressing parental well-being in child assessments.
Expected positive outcomes include improved oral hygiene knowledge, attitudes, practices, and overall oral hygiene status among children in the intervention group compared to the control group.